LT3630114T - Migalastatas, skirtas fabri ligos pacientų, turinčių inkstų funkcijos sutrikimą, gydymui - Google Patents

Migalastatas, skirtas fabri ligos pacientų, turinčių inkstų funkcijos sutrikimą, gydymui

Info

Publication number: LT3630114T
Authority: LT; Lithuania
Prior art keywords: migalastat; renal impairment; fabry patients; treating fabry; treating
Prior art date: 2017-05-30

Application number

LTEPPCT/US2018/035032T

Other languages

English (en)

Inventor

Jeff Castelli

Original Assignee

Amicus Therapeutics, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-05-30

Filing date

2018-05-30

Publication date

2024-02-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=65803261&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT3630114(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2018-05-30 Application filed by Amicus Therapeutics, Inc. filed Critical Amicus Therapeutics, Inc.

2018-05-30 Priority claimed from PCT/US2018/035032 external-priority patent/WO2018222655A1/en

2024-02-12 Publication of LT3630114T publication Critical patent/LT3630114T/lt

Links

206010062237 Renal impairment Diseases 0.000 title 1
LXBIFEVIBLOUGU-DPYQTVNSSA-N migalastat Chemical compound OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O LXBIFEVIBLOUGU-DPYQTVNSSA-N 0.000 title 1
229950007469 migalastat Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01022—Alpha-galactosidase (3.2.1.22)

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Urology & Nephrology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Biochemistry (AREA)
Zoology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

LTEPPCT/US2018/035032T 2017-05-30 2018-05-30 Migalastatas, skirtas fabri ligos pacientų, turinčių inkstų funkcijos sutrikimą, gydymui LT3630114T (lt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201762512458P	2017-05-30	2017-05-30
US201862626953P	2018-02-06	2018-02-06
PCT/US2018/035032 WO2018222655A1 (en)	2017-05-30	2018-05-30	Methods of treating fabry patients having renal impairment

Publications (1)

Publication Number	Publication Date
LT3630114T true LT3630114T (lt)	2024-02-12

Family

ID=65803261

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
LTEP23219949.7T LT4324522T (lt)	2017-05-30	2018-05-30	Fabri liga sergančių pacientų, turinčių inkstų funkcijos sutrikimą, gydymo būdai
LTEP22165669.7T LT4062916T (lt)	2017-05-30	2018-05-30	Tam tikras mutacijas turinčių fabri pacientų gydymas
LTEPPCT/US2018/035032T LT3630114T (lt)	2017-05-30	2018-05-30	Migalastatas, skirtas fabri ligos pacientų, turinčių inkstų funkcijos sutrikimą, gydymui
LTEP23219933.1T LT4327869T (lt)	2017-05-30	2018-05-30	Fabri liga sergančių pacientų, turinčių inkstų funkcijos sutrikimą, gydymo būdai

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
LTEP23219949.7T LT4324522T (lt)	2017-05-30	2018-05-30	Fabri liga sergančių pacientų, turinčių inkstų funkcijos sutrikimą, gydymo būdai
LTEP22165669.7T LT4062916T (lt)	2017-05-30	2018-05-30	Tam tikras mutacijas turinčių fabri pacientų gydymas

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
LTEP23219933.1T LT4327869T (lt)	2017-05-30	2018-05-30	Fabri liga sergančių pacientų, turinčių inkstų funkcijos sutrikimą, gydymo būdai

Country Status (14)

Country	Link
EP (9)	EP4062916B1 (lt)
CN (4)	CN111278438A (lt)
DK (4)	DK4062916T3 (lt)
ES (3)	ES2970419T3 (lt)
FI (4)	FI4062916T3 (lt)
HR (4)	HRP20240061T1 (lt)
HU (2)	HUE065615T2 (lt)
LT (4)	LT4324522T (lt)
PL (4)	PL4062916T3 (lt)
PT (4)	PT3630114T (lt)
RS (3)	RS65230B1 (lt)
SI (2)	SI3630114T1 (lt)
SM (2)	SMT202500016T1 (lt)
TW (4)	TW202322814A (lt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2021015352A (es) *	2019-06-11	2022-04-06	Amicus Therapeutics Inc	Métodos para tratar la enfermedad de fabry en pacientes que tienen insuficiencia renal.
KR20220044560A (ko) *	2019-08-07	2022-04-08	아미쿠스 세라퓨틱스, 인코포레이티드	Gla 유전자에 돌연변이를 갖는 환자에서 파브리 질병을 치료하는 방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6274597B1 (en)	1998-06-01	2001-08-14	Mount Sinai School Of Medicine Of New York University	Method of enhancing lysosomal α-Galactosidase A
PL2533050T6 (pl) *	2006-05-16	2016-05-31	Amicus Therapeutics Inc	Możliwości leczenia choroby Fabry'ego
MX2009010557A (es)	2007-03-30	2009-11-19	Amicus Therapeutics Inc	Metodo para el tratamiento de la enfermedad de fabry que utiliza chaperonas farmacologicas.
MX2009011473A (es) *	2007-04-26	2010-01-18	Amicus Therapeutics Inc	Regimenes de dosificacion para el tratamiento de enfermedades por almacenamiento lisosomal que utilizan chaperonas farmacologicas.
US9999618B2 (en) *	2007-04-26	2018-06-19	Amicus Therapeutics, Inc.	Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones
EP2946785B1 (en)	2008-02-12	2018-10-24	Amicus Therapeutics, Inc.	Method to predict response to pharmacological chaperone treatment of diseases
SG10201604757RA (en) *	2011-03-11	2016-08-30	Amicus Therapeutics Inc	Dosing regimens for the treatment of fabry disease
US20120283290A1 (en) *	2011-05-06	2012-11-08	Amicus Therapeutics Inc.	Quantitation of gl3 in urine
TW202408513A (zh)	2016-07-19	2024-03-01	美商阿米庫斯醫療股份有限公司	治療ert初治的和已經歷ert的患者中之法布瑞氏症
CA3224546C (en)	2017-05-30	2026-02-24	Amicus Therapeutics, Inc.	Use of migalastat in the treatment of fabry patients
SG11202000423XA (en) *	2017-07-19	2020-02-27	Amicus Therapeutics Inc	Treatment of fabry disease in ert-naïve and ert-experienced patients

2018
- 2018-05-30 RS RS20240113A patent/RS65230B1/sr unknown
- 2018-05-30 EP EP22165669.7A patent/EP4062916B1/en active Active
- 2018-05-30 FI FIEP22165669.7T patent/FI4062916T3/fi active
- 2018-05-30 HR HRP20240061TT patent/HRP20240061T1/hr unknown
- 2018-05-30 SM SM20250016T patent/SMT202500016T1/it unknown
- 2018-05-30 EP EP18733415.6A patent/EP3630114B1/en active Active
- 2018-05-30 EP EP23219949.7A patent/EP4324522B1/en active Active
- 2018-05-30 PL PL22165669.7T patent/PL4062916T3/pl unknown
- 2018-05-30 ES ES18733415T patent/ES2970419T3/es active Active
- 2018-05-30 SM SM20240037T patent/SMT202400037T1/it unknown
- 2018-05-30 RS RS20250010A patent/RS66376B1/sr unknown
- 2018-05-30 CN CN201880043564.XA patent/CN111278438A/zh active Pending
- 2018-05-30 LT LTEP23219949.7T patent/LT4324522T/lt unknown
- 2018-05-30 FI FIEP23219933.1T patent/FI4327869T3/fi active
- 2018-05-30 SI SI201831052T patent/SI3630114T1/sl unknown
- 2018-05-30 EP EP24164126.5A patent/EP4374918B1/en active Active
- 2018-05-30 HR HRP20260346TT patent/HRP20260346T1/hr unknown
- 2018-05-30 RS RS20260292A patent/RS67849B1/sr unknown
- 2018-05-30 EP EP23219933.1A patent/EP4327869B1/en active Active
- 2018-05-30 FI FIEP18733415.6T patent/FI3630114T3/fi active
- 2018-05-30 FI FIEP23219949.7T patent/FI4324522T3/fi active
- 2018-05-30 DK DK22165669.7T patent/DK4062916T3/da active
- 2018-05-30 HR HRP20260335TT patent/HRP20260335T1/hr unknown
- 2018-05-30 TW TW112104527A patent/TW202322814A/zh unknown
- 2018-05-30 PT PT187334156T patent/PT3630114T/pt unknown
- 2018-05-30 LT LTEP22165669.7T patent/LT4062916T/lt unknown
- 2018-05-30 LT LTEPPCT/US2018/035032T patent/LT3630114T/lt unknown
- 2018-05-30 EP EP22165647.3A patent/EP4062915A1/en not_active Withdrawn
- 2018-05-30 CN CN202311285883.0A patent/CN117357524A/zh active Pending
- 2018-05-30 DK DK18733415.6T patent/DK3630114T3/da active
- 2018-05-30 PL PL18733415.6T patent/PL3630114T3/pl unknown
- 2018-05-30 HR HRP20241738TT patent/HRP20241738T1/hr unknown
- 2018-05-30 TW TW107118443A patent/TWI795408B/zh active
- 2018-05-30 EP EP25176976.6A patent/EP4635496A1/en active Pending
- 2018-05-30 ES ES24164126T patent/ES3052647T3/es active Active
- 2018-05-30 PT PT232199331T patent/PT4327869T/pt unknown
- 2018-05-30 SI SI201831193T patent/SI4062916T1/sl unknown
- 2018-05-30 PL PL23219933.1T patent/PL4327869T3/pl unknown
- 2018-05-30 EP EP23219922.4A patent/EP4327868A2/en not_active Withdrawn
- 2018-05-30 TW TW110119149A patent/TWI775453B/zh active
- 2018-05-30 CN CN202510610323.0A patent/CN120732857A/zh active Pending
- 2018-05-30 DK DK23219933.1T patent/DK4327869T3/da active
- 2018-05-30 LT LTEP23219933.1T patent/LT4327869T/lt unknown
- 2018-05-30 HU HUE18733415A patent/HUE065615T2/hu unknown
- 2018-05-30 PT PT232199497T patent/PT4324522T/pt unknown
- 2018-05-30 CN CN202411682885.8A patent/CN119587544A/zh active Pending
- 2018-05-30 PL PL23219949.7T patent/PL4324522T3/pl unknown
- 2018-05-30 HU HUE22165669A patent/HUE069837T2/hu unknown
- 2018-05-30 PT PT221656697T patent/PT4062916T/pt unknown
- 2018-05-30 DK DK23219949.7T patent/DK4324522T3/da active
- 2018-05-30 TW TW112150982A patent/TWI894750B/zh active
- 2018-05-30 EP EP23189734.9A patent/EP4245366A3/en not_active Withdrawn
- 2018-05-30 ES ES22165669T patent/ES3002433T3/es active Active

Also Published As

Publication number	Publication date
EP4374918A3 (en)	2024-08-14
EP3630114B1 (en)	2023-11-01
HUE069837T2 (hu)	2025-04-28
HRP20241738T1 (hr)	2025-02-28
EP4327869A3 (en)	2024-05-22
PT4327869T (pt)	2026-03-12
DK3630114T3 (da)	2024-01-29
EP4374918B1 (en)	2025-07-16
FI3630114T3 (fi)	2024-01-30
LT4327869T (lt)	2026-03-25
TWI775453B (zh)	2022-08-21
EP4324522A2 (en)	2024-02-21
RS65230B1 (sr)	2024-03-29
EP4324522B1 (en)	2025-12-10
EP4324522A3 (en)	2024-05-22
LT4062916T (lt)	2025-01-10
SI3630114T1 (sl)	2024-03-29
PT3630114T (pt)	2024-02-01
EP4327869A2 (en)	2024-02-28
EP4635496A1 (en)	2025-10-22
RS67849B1 (sr)	2026-03-31
EP4327868A2 (en)	2024-02-28
TW202322814A (zh)	2023-06-16
SMT202400037T1 (it)	2024-03-13
EP4245366A9 (en)	2023-12-06
EP4062916B1 (en)	2024-10-09
CN117357524A (zh)	2024-01-09
CN119587544A (zh)	2025-03-11
FI4327869T3 (fi)	2026-03-09
PL4324522T3 (pl)	2026-04-27
HRP20260335T1 (hr)	2026-04-10
CN120732857A (zh)	2025-10-03
EP4374918A2 (en)	2024-05-29
ES2970419T3 (es)	2024-05-28
PL4327869T3 (pl)	2026-04-27
LT4324522T (lt)	2026-03-25
PT4062916T (pt)	2025-01-13
ES3052647T3 (en)	2026-01-12
TW201900165A (zh)	2019-01-01
FI4062916T3 (fi)	2025-01-10
HRP20260346T1 (hr)	2026-04-24
EP4062915A1 (en)	2022-09-28
EP3630114A1 (en)	2020-04-08
EP4327869B1 (en)	2025-12-10
FI4324522T3 (fi)	2026-03-09
SI4062916T1 (sl)	2025-04-30
HUE065615T2 (hu)	2024-06-28
DK4327869T3 (da)	2026-03-16
EP4245366A3 (en)	2023-11-29
ES3002433T3 (en)	2025-03-06
EP4062916A1 (en)	2022-09-28
TWI795408B (zh)	2023-03-11
TWI894750B (zh)	2025-08-21
TW202440104A (zh)	2024-10-16
RS66376B1 (sr)	2025-02-28
EP4245366A2 (en)	2023-09-20
PL4062916T3 (pl)	2025-03-17
CN111278438A (zh)	2020-06-12
PL3630114T3 (pl)	2024-03-25
HRP20240061T1 (hr)	2024-03-29
DK4062916T3 (da)	2025-01-13
TW202140000A (zh)	2021-11-01
DK4324522T3 (da)	2026-03-16
SMT202500016T1 (it)	2025-03-12
PT4324522T (pt)	2026-03-13

Publication	Publication Date	Title
GB201813876D0 (en)	2018-10-10	Treatment
GB201800546D0 (en)	2018-02-28	Treatment
GB201802795D0 (en)	2018-04-04	Patient assessment method
GB201709093D0 (en)	2017-07-19	Patient monitoring system
GB2552872B (en)	2018-08-29	Patient monitoring system
PL3612475T3 (pl)	2021-12-27	Instalacja obróbkowa
ZA201805245B (en)	2019-10-30	Method for treating cancer patients with severe renal impairment
PL3668563T3 (pl)	2022-02-21	Cewnik do dializy
SG11202102878TA (en)	2021-04-29	Treatment methods
SG11202102827YA (en)	2021-04-29	Treatment methods
GB201604658D0 (en)	2016-05-04	Treatment for pain
SI3630114T1 (sl)	2024-03-29	Migalastat za zdravljenje bolnikov s fabryevo boleznijo, z ledvično okvaro
GB201717555D0 (en)	2017-12-06	Blood filter
GB201718985D0 (en)	2018-01-03	Treatment
PL3730200T3 (pl)	2022-12-27	Ulepszony system filtrów
HUE049399T2 (hu)	2020-09-28	Mandzsetta ortopédiai kezeléshez
IL287840A (en)	2022-01-01	treatment system
ZA201805215B (en)	2019-07-31	Preparation for nasal-nasopharyngeal treatment
GB201814905D0 (en)	2018-10-31	Treatment
GB201902578D0 (en)	2019-04-10	Treatment
GB201802269D0 (en)	2018-03-28	Handbarrow for carrying patients
ZA201801814B (en)	2018-12-19	Patient assessment
GB201803009D0 (en)	2018-04-11	Forth alzheimers treatment
GB201713650D0 (en)	2017-10-11	Treatment
GB201711677D0 (en)	2017-09-06	Combination treatment